Department of Hepatobiliary Surgery, First Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Xi'an 710061, China.
Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):512-9. doi: 10.1016/s1499-3872(13)60081-8.
Portal vein thrombosis (PVT) is a potential lethal complication and may have negative influence on the prognosis after splenectomy in patients with liver cirrhosis. Prevention and timely detection of PVT are quite significant. There is a lack of knowledge about the clinical features and risk factors of PVT. Our study aimed to investigate the risk factors and clinical characteristics of PVT in order to figure out the high-risk individuals.
We collected the clinical data of 472 consecutive patients with non-neoplastic liver cirrhosis who had undergone splenectomy from January 2008 to December 2010 in our institution. Clinical and surgical characteristics of patients who developed PVT postoperatively and those who did not develop PVT were compared. Univariate and multivariate analyses of risk factors of PVT were performed. The mortality and rebleeding rate of the patients were also evaluated.
Of the 472 patients, 52 were excluded from the study. PVT developed in 71 (71/420, 16.9%) patients. Multivariate analysis revealed that wider preoperative portal vein diameter, postoperative thrombocytosis, prolonged prothrombin time and periesophagogastric devascularization were significantly correlated with PVT development [odds ratio (OR): 5.701, 2.807, 1.850 and 2.090, respectively]. The incidence of PVT in patients who took antiplatelet drugs was not lower than that in those who did not. Follow-up showed that patients in the PVT group had a tendency towards reduced overall survival but it was not statistically significant. Gastrointestinal bleeding occurred more often in the PVT group than that in the non-PVT group (P=0.044).
Wider preoperative portal vein diameter, postoperative thrombocytosis, prolonged prothrombin time and periesophagogastric devascularization are independent risk factors of PVT. PVT is related with higher risk of postoperative gastrointestinal hemorrhage but has no significant impact on the overall survival.
门静脉血栓形成(PVT)是一种潜在的致命并发症,可能对肝硬化患者脾切除术后的预后产生负面影响。预防和及时发现 PVT 非常重要。目前对于 PVT 的临床特征和危险因素知之甚少。我们的研究旨在探讨 PVT 的危险因素和临床特征,以确定高危人群。
我们收集了 2008 年 1 月至 2010 年 12 月期间在我院接受非肿瘤性肝硬化脾切除术的 472 例连续患者的临床资料。比较了术后发生 PVT 和未发生 PVT 的患者的临床和手术特征。对 PVT 的危险因素进行了单因素和多因素分析。还评估了患者的死亡率和再出血率。
在 472 例患者中,有 52 例被排除在研究之外。71 例(71/420,16.9%)患者发生 PVT。多因素分析显示,术前门静脉直径较宽、术后血小板增多、凝血酶原时间延长和胃食管周围血管离断与 PVT 发生显著相关[比值比(OR):5.701、2.807、1.850 和 2.090]。服用抗血小板药物的患者发生 PVT 的发生率并不低于未服用的患者。随访显示,PVT 组患者的总体生存率有降低趋势,但无统计学意义。PVT 组的胃肠道出血发生率高于非 PVT 组(P=0.044)。
术前门静脉直径较宽、术后血小板增多、凝血酶原时间延长和胃食管周围血管离断是 PVT 的独立危险因素。PVT 与术后胃肠道出血风险增加有关,但对总体生存率无显著影响。